Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$29.06 - $38.83 $501,546 - $670,166
-17,259 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$42.46 - $56.58 $138,164 - $184,111
3,254 Added 23.23%
17,259 $797,000
Q3 2020

Nov 13, 2020

SELL
$37.44 - $64.63 $759,957 - $1.31 Million
-20,298 Reduced 59.17%
14,005 $607,000
Q2 2020

Aug 12, 2020

BUY
$17.62 - $58.71 $604,418 - $2.01 Million
34,303 New
34,303 $1.82 Million

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $5.32M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.